Effects of Oxaliplatin-Induced Peripheral Neuropathy on Hand Function, Grip Strength and Quality of Life in Colorectal Cancer Patients
NCT07203066 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 84
Last updated 2025-10-02
Summary
The aim of this study is to investigate the effects of oxaliplatin-induced peripheral neuropathy on hand function, grip strength, and quality of life in colorectal cancer patients. Assessing the motor symptoms of CIPN and sharing the results in clinical settings will help guide evidence-based practices and interventions.
Conditions
- Peripheral Neuropathy Due to Chemotherapy
- Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
- Hand Strength
Interventions
- OTHER
-
observational only
observational only
Sponsors & Collaborators
-
Acibadem University
collaborator OTHER -
Fenerbahce University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-24
- Primary Completion
- 2025-12-24
- Completion
- 2026-02-24
More Related Trials
-
Pharmacogenomic Study to Predict Neurotoxicity of Oxaliplatin
NCT00977717 ·Status: COMPLETED
-
Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens
NCT00603577 ·Status: TERMINATED ·Phase: PHASE3
-
The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy
NCT02024191 ·Status: UNKNOWN ·Phase: PHASE3
-
XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy
NCT00272051 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Neuropathic Pain From Oxaliplatin by Photobiomodulation
NCT06199115 ·Status: RECRUITING ·Phase: NA
-
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
NCT04137107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin
NCT02169908 ·Status: COMPLETED ·Phase: NA
-
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
NCT07320950 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
NCT00305188 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis
NCT01523574 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy
NCT03958747 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy and Safety of PerOx Quench on the Prevention of Oxaliplatin Treatment Induced Neuropathy
NCT02560740 ·Status: TERMINATED ·Phase: NA
-
Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel
NCT06538272 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer
NCT02251977 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients
NCT02415829 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy
NCT07285356 ·Status: RECRUITING ·Phase: NA
-
A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
NCT04492436 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neurotoxic Symptoms in Adjuvant Chemotherapy in Patients With Colorectal Cancer
NCT02412683 ·Status: COMPLETED
-
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
NCT07046650 ·Status: RECRUITING ·Phase: PHASE2
-
Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy
NCT06722950 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study Evaluating Neurotoxicity in Patients With Metastatic Gastro Intestinal Cancer Taking Phycocare® or Placebo During Oxaliplatin Based Chemotherapy
NCT05025826 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study
NCT05254639 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Cisplatin-Induced Peripheral Neuropathy in Patients With Germ Cell Tumor
NCT02677727 ·Status: COMPLETED
-
Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients
NCT01611727 ·Status: COMPLETED ·Phase: PHASE2
-
The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy
NCT05624138 ·Status: RECRUITING ·Phase: PHASE3